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Abstract 
Reaction of hydrazinecarbothioamides with 2-bromoacetophenones furnished the formation of thiazole-, bis-
thiazole-, pyrazole- and 1,3,4-thiadiazole- derivatives in good yields. The mechanism was discussed. The 
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Introduction 
 
Substituted hydrazinecarbothioamides were found to exhibit antifungal,1-3 antiviral4 and antioxidant 
activities5. Free radicals and reactive sulfur species such as thiol radicals are frequently synthesized through 
many biological processes and may be considered as indicators of biological inadequacy. In recent times, the 
applications of thiazoles have found in drug development for the treatment of allergies6, hypertension,7 
inflammation,8 schizophrenia,9 bacterial,10 HIV infections,11 and hypnotics12. Moreover, thiazoles have been 
used for the treatment of pain,13 as fibrinogen receptor antagonists with antithrombotic activity14 and as new 
inhibitors of bacterial DNA gyrase B.15 Mukhija it was reported that thiourea reacted quantitatively with 
various 2-halocarbonyl compounds to form 2-amino salts of thiazoles.16 Many classes of thiadiazole have been 
known to possess interesting widespread biological properties such as antimicrobial,17 and anticancer.18,19 
Previously, we utilized by N,N’-disubstituted-hydrazinecarbothioamides in heterocyclic synthesis, such as 1,3-
thiazin-2-ylidene-substituted hydrazides and 1,2,4-triazolo[3,4-b]-1,3-thiazine-5-carboxylates20. Continuation 
of our research program included the synthesis of various thiazoles,21-26 we herein report the results of our 




Results and Discussion 
 
Pleasingly, treatment of N,N’-disubstituted-hydrazinecarbothioamides 1a-d with 2-bromoacetophenones 2a,b 
at room temperature afforded the corresponding thiazoles 3cb (80%), 4bb (82%), 5ba (90%), and 6db (87%) 
(Scheme 1). (1E,2E)-1,2-Bis(5-methyl-4-phenyl-3-(p-tolyl)thiazol-2(3H)-ylidene)-hydrazine (7da) was also 
obtained in 74% yield (Scheme 1), during the reaction of 1d with 2a. Reaction of allyl hydrazinecarbothioamide 
derivative 1a with 2b, gave pyrazole 8ab in 75% yield (Scheme 1). Finally, and on reacting 1c with 2a, the 
known 1,3,4-thiadiazole 9c was obtained in 72% yield (Scheme 1).  
The structures of thiazoles 3cb, 4bb, 5ba, and 6db were elucidated by IR, NMR, mass spectra and 
elemental analyses. For 3cb, its molecular formula was proved from elemental analysis and mass spectrometry 
as C28H22N4S2 (Experimental section). The IR spectrum of 3cb showed absorption band at = 3330-3320 cm-1 
for the NH group. No absorption was noted for carbonyl or hydroxyl groups in the IR spectrum. The 1H NMR 
spectrum of 3cb showed two broad singlets; each for one proton at  = 11.45 and 11.30 assigned to the two 
protons of thiourea. In 13C NMR spectrum of 3cb, it was observed carbon signals at C = 181.0 for C=S, 154.0 
(thiazole-C-2), and 118.4 ppm for C-5 of thiazole moiety (Experimental Section).  
For compound 4bb, its molecular formula was proved by mass spectrometry and elemental analysis as 
C30H26N4S2 (Experimental Section). Mass spectrum showed also the molecular ion peak at m/z = 506 (55%), 
whereas the basic ion peak at m/z = 91, which related to the prescence of benzylic fragment pattern. The IR 
spectra of 4bb showed the NH groups at = 3220-3215 cm-1. In the 1H NMR spectral data of 4bb 
(Experimental Section), it can be seen two broad singlets appeared at H = 10.25 and 10.08 ppm, which 
assigned to the two NH thiourea protons. Moreover, the two-dissimilar benzylic-CH2 protons resonated at H = 
4.86 and 5.02 ppm, respectively. The 13C NMR spectra was also in accordance to the proposed structure and 
showed the functional groups of carbon signals C = 181.0 for the thioamide carbon and the two benzylic 
carbons at C = 48.9 and 46.9 (Experimental section). The thiazole carbon signals were also resonated at C = 
156.8 (C-2), 145.0 (C-4) and 118.3 (thiazole-C-5). 
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Scheme 1. Reactions of hydrazinecarbothioamides 1a-d with 2-bromoacetophenones 2a,b. 
 
When, the derivative 1b reacted with 2-bromo-1-phenylpropan-1-one (2a), the reaction gave thiazole 5ba 
(Scheme 1). Mass spectrum of 5ba showed the molecular peak at m/z = 444. The 1H NMR spectrum of 
compound 5ba gave two broad singlets at H = 10.20 and 8.20 for the two NH thiourea protons (Experimental 
Section). Moreover, the asymmetrical structure was corroborated via appearance of three singlets at H = 4.8, 
5.0, 2.3 and 2.1 of the two benzylic-CH2 protons, CH3 and thiol-H, respectively. The 13C NMR spectrum 
supported the 1H NMR spectroscopic data due to the prescence of the thione-C, thiazole-C-2 and the two 
benzylic carbons at C =179.7, 156.6, 48.9, and 46.4, respectively. (Experimental Section). Again, and in case of 
6db, the two NH protons absorbed as two broad singlets at H =11.00 and 10.20. Most indicative that 13C NMR 
spectrum of 6db elucidated the asymmetric structure of 6db via the appearance the two carbon signals of the 
p-toyl-methyl groups at C = 21.2 and 21.4 (see Experimental Section). 
Under the condition mentioned above, 1d reacted with 2a to give the bis-thiazole 7da in 74% yield 
(Scheme 1). The IR spectrum of 7da didn’t reveal any absorption corresponding to NH, OH and C=S groups 
(Experimental Section). Mass and elemental analysis revealed that the molecular weight of 7da equals to the 
sum of 1d with two moles of 2a accompanied with elimination of two molecules of hydrogen bromide. In the 
meanwhile, 13C NMR spectrum reveal carbon signals of an asymmetric molecule. Disappearance of the thione 
carbon in 13C NMR spectrum, indicated that it was involved in cyclization process. The structure of E-
configuration in 7da was ultimately proved by X-ray structural analysis (Figure 1). 
The suggested mechanism described the formation of thiazoles 3cb, 4bb, 5ba and 6db was based upon 
attacking of thione-lone pair to the -bromo-C in 2a,b (Scheme 2). That was followed by salt formation as in 
intermediate 10. Subsequently, salt 10 would be neutralized and nitrogen lone-pair would attack to the 
carbonyl-C to form intermediate 11. Elimination of water and HBr from 11 would give the thiazoles 3cb, 4bb, 
5ba and 6db (Scheme 2). Ultimately, addition of a second molecule of 2a to 11 along with extrusion of two 
molecules of water and HBr, would produce 7da (Scheme 2). 
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Scheme 2. Suggested mechanism describing the formation of thiazoles 3cb, 4bb, 5ba, 6bb and free bis-
thiazole 7da. 
 
In different manner, reaction of equal equivalents of both 1a with 2-bromo-1,2-diphenylethan-1-one (2b) 
gave pyrazole 8ab (Scheme 1). The IR spectrum of 8ab showed the NH and aliphatic groups at  = 3425-3400 
and 2933-2974 cm-1, respectively. The mass and elemental analysis elucidated the gross molecular formula of 
8ab as C18H17N3. Mass spectrum showed the molecular ion peak at m/z = 275 (51%), whereas the base peak at 
m/z = 102. The 1H NMR spectrum proved the prescence of allyl group and its protons. The NH-pyrazole was 
absorbed in 1H NMR at H =12.00 (Experimental Section). The 13C NMR spectrum supported the 1H NMR 
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spectroscopic data via the appearance of the allylic-carbons at C = 45.7, 114.8 and 133.3. The structure of 8ab 




Scheme 3. Suggested mechanism describing the formation of compound 8ab. 
 
The suggested mechanism for the formation of 8ab starts also from the salt 10 (Scheme 3). Neutralization 
accompanied by elimination of HBr molecule, then addition of nitrogen-lone pair of the N-2 of the hydrazine 
group to the carbonyl-C would give intermediate 13 (Scheme 3). Elimination of water molecule from 13 would, 
thus, give 14. Rearrangement was then occurred via amidine-like reaction to C-6 of the formed thiadiazine 
would led to salt 15. Elimination of allyl isothiocyanate and extrusion of sulfur from 15 would, finally give 8ab 
(Scheme 3).  
Finally, on reacting hydrazinecarbothioamide derivative 1c with 2a, the reaction yielded the known 
product 9c27, Scheme 1). Heating the compound 1c alone under the same condition didn’t proceed to give 9c, 
therefore we concluded that the presence of 2a would enhance the formation of thiadiazole 9c. Starting from 
the previous formed intermediate 10, the other thione-lone pair would attack to the positively charged 
thiamido-C to form salt 16 (Scheme 4). Rearrangement and neutralization process in 16 and recombination of 
the eliminated Br anion would form 10 and recycled compound 2a together with extrusion of H2S (Scheme 4). 
Based upon TLC analysis with authentic sample of known N,N’-diphenyl-1,3,4-thiadiazole-2,5-diamine27 and its 
IR and 1H NMR, the structure compound 9c was proved.  
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Our paper describes the synthesis of different types of heterocycles during the reactions of 
hydrazinecarbothioamides with electrophilic reagents. Therefore, much work will be done in our lab to 





General. Melting points were determined on Stuart electrothermal melting point apparatus and were 
uncorrected. TLC analysis was performed on analytical Merck 9385 silica aluminum sheets (Kiselgel 60) with 
PF254 indicator. The IR spectra were recorded as KBr disks on Shimadzu-408 infrared spectrophotometer, 
Faculty of Science, Minia University. The NMR spectra were measured using a Bruker AV-400 spectrometer at 
the Karlsruhe Institut für Technologie (KIT), Institute of Organic Chemistry, Karlsruhe, Germany. Chemical 
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shifts were expressed as δ (ppm) with tetramethylsilane as internal reference. The samples were dissolved in 
DMSO-d6, s = singlet, d = doublet, dd = doublet of doublet and t = triplet. Mass spectrometry were recorded on 
a Varian MAT 312 instrument in EI mode (70 eV), at the Karlsruhe Institut für Technologie (KIT), Institute of 
Organic Chemistry, Karlsruhe, Germany. Elemental analyses were carried out using Varian Elementary device 
in National Research Center, Giza, Egypt. 
 
Starting materials. N,N’-Disubstituted-hydrazinecarbothioamides were prepared according to published 
procedures as were N,N’-diallylhydrazine-1,2-dicarbothioamide (1a)27, N,N’-bis(benzyl)hydrazine-1,2-
dicarbothioamide (1b), N,N’-diphenylhydrazine-1,2-dicarbothioamide (1c)27, N,N’-bis(4’-methylphenyl)-
hydrazine-1,2-dicarbothioamide (1d).28 2-Bromoacetophenones 2a,b were bought from Aldrich. 
General Procedure: reaction of hydrazinecarbothioamides 1a-d with 2-bromoacetophenones 1a,b. A mixture 
of hydrazinecarbothioamides (1a-d, 1 mmol) and 2-bromoacetophenones (2a,b, 1 mmol) in 30 mL dry EtOH 
together 0.5 mL of triethyl amine were stirred at room temperature for 10-12 h (the reaction was followed up 
by TLC analysis). In case of reaction between 1a and 2b, the reaction was completed after refluxing the 
reaction mixture for 3h. The formed precipitates were allowed to stand overnight and they were collected by 
suction filtration. The precipitates were then washed with cyclohexane, and dried at room temperature. 
Compounds 3cb, 4bb, 5ba, 6db, free bis-thiazole 7da, pyrazole 8ab and thiadiazole 9c were obtained and were 
recrystallized from the stated solvents. 
N-Phenyl-2-(3,4,5-triphenylthiazol-2(3H)-ylidene)hydrazine-1-carbothioamide (3cb). Yellow crystals (EtOH), 
yield: 0.38 g (80%), M.p.: 235 -7 oC (decomp.). IR (KBr):  = 3330-3320 (NH), 3030 (Ar-CH), 1620 (C=N), 1590 
(C=C), 1366 (C=S) cm-1; 1H NMR (400 MHz, DMSO-d6): H = 11.45 (bs, 1H, NH), 11.30 (bs, 1H, NH), 7.80-7.75 (m, 
2H, Ph-H), 7.70-7.65 (m, 2H, Ph-H), 7.56-7.46 (m, 5H, Ph-H), 7.30-7.15 (m, 5H, Ph-H), 7.00-6.85 (m, 4H, Ph-H), 
6.80-6.75 (m, 2H) ppm. 13C NMR (100 MHz, DMSO-d6): C  = 181.0 (C=S), 154.0 (thiazole-C-2), 144.4 (thiazole-C-
4), 138.3, 136.4 (Ar-N-C), 130.2, 130.0 (Ph-C), 128.4, 128.2, 127.8, 127.6, 127.4, 127.2, 127.0 (Ar-2CH), 126.8, 
126.6, 126.4, 126.0 (Ar-CH), 125.8 (Ar-2CH), 118.4 (thiazole-C-5) ppm. MS (70 eV, Fab mass, %): m/z = 478 
(92%), 385 (17), 328 (32), 268 (38), 152 (100). C28H22N4S2 (478.18): Calcd. C, 70.26; H, 4.63; N, 11.71. Found: C, 
70.16; H, 4.60; N, 11.60.  
N-Benzyl-2-(3-benzyl-4,5-diphenylthiazol-2(3H)-ylidene)hydrazine-1-carbothioamide (4bb). Orange crystals 
(DMF/EtOH), yield: 0.41 g (82%), M.p.: 200-2 °C (decomp.).IR (KBr):   = 3220-3215 (NH), 3030 (Ar-CH), 2777 
(Aliph.-CH), 1581 (C=N), 1560 (C=C), 1370 (C=S) cm-1; 1H NMR (400 MHz, DMSO-d6): H =10.25 (bs, 1H, NH), 
10.08 (bs, 1H, NH), 7.80-7.76 (m, 2H, Ar-H), 7.70-7.50 (m, 5H, Ar-H), 7.30-7.15 (m, 4H, Ar-H), 7.00-6.86 (m, 2H, 
Ar-H), 6.80-6.50 (m, 7H, Ar-H), 5.02 (bs, 2H, CH2-benzyl), 4.86 (bs, 2H, CH2-benzyl) ppm. 13C NMR (100 MHz, 
DMSO-d6): C = 181.0 (C=S), 156.8 (thiazole-C-2), 145.0 (thiazole-C-4), 138.3, 136.4 (Ar-N-C), 131.6, 131.0 (Ph-
C), 128.5, 128.3, 128.0, 127.9, 127.8, 127.6, 127.5, 127.2 (Ar-2CH), 126.4, 126.0, 125.8, 125.4 (Ar-CH), 118.3 
(thiazole-C-5), 48.90, 46.9 (benzylic-CH2) ppm. MS (70 eV, Fab mass, %): m/z = 506 (55%), 91 (100). C30H26N4S2 
(506.16): Calcd. C, 71.12; H, 5.17; N, 11.06. Found: C, 71.00; H, 5.08; N, 11.10.  
N-Benzyl-2-(3-benzyl-5-methyl-4-phenylthiazol-2(3H)-ylidene)hydrazine-1-carbothioamide (5ba). Brown 
crystals (DMF/EtOH), 0.40 g (90%), M.p.: 260-2 °C (decomp.). IR (KBr):   = 3330-3260 (NH), 3060-3030 (Ar-CH), 
2900-2820 (Aliph.-CH), 1630, 1610 (C=N), 1560 (C=C) cm-1; 1H NMR (400 MHz, DMSO-d6): H =10.20 (s, 1H, NH-
thiourea), 8.20 (bs, 1H, NH-thiourea), 7.60-7.50 (m, 5H, Ar-H), 7.35-7.10 (m, 5H, Ar-H), 6.94-6.86 (m, 5H, Ar-H), 
5.00 (bs, 2H, CH2-benzyl), 4.80 (bs, 2H, CH2-benzyl), 2.30 (s, 3H, CH3) ppm. 13C NMR (100 MHz, DMSO-d6): C = 
179.7 (C=S), 169.7 (C-2), 144.7 (C-5), 139.1 (C-4), 133.2, 132.1, 131.3 (Ar-C), 129.2, 128.8, 128.6, 127.8 (Ar-
2CH), 126.8, 126.6, 126.2 (Ar-CH-p), 124.8, 124.4 (Ar-2CH), 48.9, 46.4 (benzyl-CH2), 22.0 (CH3) ppm. MS (70 eV, 
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Fab mass, %): m/z = 444 ([M+, 100). C25H24N4S2 (444.62): Calcd. C, 67.54; H, 5.44; N, 12.60. Found: C, 67.40; H, 
5.58; N, 12.70.  
2-(4,5-Diphenyl-3-(p-tolyl)thiazol-2(3H)-ylidene-N-(p-tolyl)hydrazine-1-carbothioamide (6db). Brown crystals 
(DMF/EtOH), 0.45 g (87%), M.p. 282-4 °C (decomp.). IR (KBr):    = 3340-3210 (NH), 3090 (Ar-CH), 2900-2820 
(Aliph.-CH), 1630, 1620 (C=N), 1570 (C=C) cm-1; 1H NMR (400 MHz, DMSO-d6): H =11.00 (s, 1H, NH-thiourea), 
10.20 (bs, 1H, NH-thiourea), 7.60-7.57 (dd, 2H, J = 7.8, 0.7 Hz, Ar-H), 7.40-7.15 (m, 5H, Ar-H), 7.20-7.00 (m, 5H, 
Ar-H), 6.80-6.65 (m, 4H, Ar-H), 6.56-6.52 (dd, 2H, J = 7.8, 1.0 Hz, Ar-H), 2.40 (s, 3H, CH3-Ar-C), 2.20 (s, 3H, CH3-
Ar-C) ppm. 13C NMR (100 MHz, DMSO-d6): C = 180.0 (C=S), 168.0 (C=N), 144.5 (C-5), 139.2 (C-4), 138.2, 138.0 
(Ar-N-C), 136.2, 135.4 (Ar-C-CH3), 132.3, 130.1 (Ar-C), 128.8, 128.7, 128.6, 128.0, 127.8, 127.6, 127.2 (Ar-2CH), 
126.6, 126.4 (Ar-CH-p), 124.8 (Ar-2CH), 22.3, 22.1 (CH3-Ar) ppm. MS (70 eV, Fab mass, %): m/z = 506 ([M+], 
100). C30H26N4S2 (506.68): Calcd. C, 71.11; H, 5.17; N, 11.06. Found: C, 71.20; H, 5.10; N, 11.28. 
(1E,2E)-1,2-Bis(5-methyl-4-phenyl-3-(p-tolyl)thiazol-2(3H)-ylidene)hydrazine (7da). Yellow crystals 
(DMF/EtOH), yield: 0.41 g (74%), M.p. = 230-232 oC. IR (KBr):   = 3030-3009 (Ar-CH), 2960, 2940 (Aliph-CH), 
1630-1610 (C=N), 1560 (C=C) cm−1; 1H NMR (400 MHz, DMSO-d6): H = 7.75-7.70 (dd, 4H, J = 8.0, 0.9 Hz, Ar-H), 
7.40-7.20 (m, 6H, Ar-H), 7.10-6.80 (m, 8H, Ar-H), 2.26 (s, 6H, CH3), 2.20 (s, 6H, Ar-CH3) ppm.13C NMR (100 MHz, 
DMSO-d6): C = 163.2 (2C-2, thiazole), 147.8 (2C-4, thiazole), 139.8 (Ar-2C-N), 136.8, 131.0 (Ph-2C), 128.6, 
128.5, 127.8 (Ar-4CH), 126.5 (Ph-2CH-p), 120.4 (Ar-4CH), 90.6 (2C-5, thiazole), 22.0, 18.9 (2CH3) ppm. MS (70 
eV, Fab mass, %): m/z = 559 (M + 1, 22), 558 (M+, 34), 250 (100), 101 (30). C34H30N4S2 (558.76): Calcd. C, 73.09; 
H, 5.41; N, 10.03. Found: C, 73.30; H, 5.30; N, 10.0. 
N-Allyl-4,5-diphenyl-1H-pyrazole-3-amine (8ab). Buff crystals (EtOH), yield: 0.20 g (75%), M.p.: 140-142 °C. IR 
(KBr):  = 3425-3400 (NH), 2933, 2974 (Aliph-CH), 1641-1601 (C=N), 1533 (C=C) cm−1; 1H NMR (400 MHz, 
DMSO-d6): H = 12.00 (bs, 1H, Pyrazole- NH pyrazole), 7.80-7.60 (m, 6H, Ph-H), 7.45-7.30 (m, 5H, Ph-H, allyl-
NH), 5.80 (m, 1H, allyl-CH= ), 5.30-5.40 (m, 2H, allyl-CH2), 3.90 (m, 2H, CH2-allyl) ppm.13C NMR (100 MHz, 
DMSO-d6): C = 143.0 (pyrazole-C-3), 139.8 (pyrazole-C-5), 136.0, 133.4 (Ph-C), 133.3 (allyl-CH=), 129.0, 128.6, 
(Ar-2CH), 127.8, 127.8 (Ar-CH-p), 127.8, 127.4 (Ar-2CH), 114.8 (allyl-CH=0), 112.0 ( pyrazole-C4), 45.7 (allyl-
CH2) ppm. MS (70 eV, Fab mass, %): m/z = 275 (51), 102 (100). C18H17N3 (275.36): Calcd. C, 78.52; H, 6.22; N, 
15.26. Found: C, 78.40; H, 6.10; N, 15.12. 
N,N’-Diphenyl-1,3,4-thiadiazole-2,5-diamine (9c). Colorless crystals (MeOH), yield: 0.19 g (72%), M.p.: 240 °C 
(lit.27 239–240°C). 
Crystal Structure Determinations. The single-crystal X-ray diffraction study were carried out on a Bruker D8 
Venture diffractometer with Photon100 detector at 123(2) K using Cu-Kradiation (= 1.54178 Å. Direct 
Methods (SHELXS-97)29 were used for structure solution and refinement was carried out using SHELXL-2014 
(full-matrix least-squares on F2)30. Hydrogen atoms were localized by difference electron density 
determination and refined using a riding model (H(N) free). Semi-empirical absorption corrections were 
applied. For 8ab an extinction correction was applied. 
7da: orange crystals, C34H30N4S2, Mr = 558.74, crystal size 0.12 × 0.08 × 0.06 mm, monoclinic, space group 
P21/c (No. 14), a = 9.7213(3) Å, b = 13.9974(4) Å, c = 10.8289(3) Å, β = 103.137(2)°, V = 1434.96(7) Å3, Z = 2, ρ 
= 1.293 Mg/m-3, µ(Cu-K) = 1.911 mm-1, F(000) = 588, 2max = 144.4°, 21286 reflections, of which 2822 were 
independent (Rint = 0.054), 183 parameters, R1 = 0.040 (for 2354 I > 2σ(I)), wR2 = 0.102 (all data), S = 1.05, 
largest diff. peak / hole = 0.322 / -0.211 e Å-3. 
8ab: yellow crystals, C18H17N3, Mr = 275.34, crystal size 0.36 × 0.30 × 0.06 mm, monoclinic, space group C2/c 
(No. 15), a = 29.1406(8) Å, b = 11.0744(3) Å, c = 9.2494(2) Å, β = 104.998(1)°, V = 2883.23(13) Å3, Z = 8, ρ = 
1.269 Mg/m-3, µ(Cu-K) = 0.596 mm-1, F(000) = 1168, 2max = 144.4°, 18490 reflections, of which 2847 were 
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independent (Rint = 0.031), 197 parameters, 2 restraints, R1 = 0.034 (for 2572 I > 2σ(I)), wR2 = 0.084 (all data), 
S = 1.04, largest diff. peak / hole = 0.217 / -0.201 e Å-3. 
The CCDC 1553071 (7da), and CCDC 1553072 (8ab) contain the supplementary crystallographic data for this 
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